Combination screens for combination therapies
نویسندگان
چکیده
منابع مشابه
Nanomedicine formulations for combination therapies
N anomedicine formulations are nanometer-sized carrier materials designed for improving the biodistribution of systemically applied (chemo-) therapeutic drugs. Clinically relevant examples of nano-medicine formulations are liposomes, polymers and micelles. By delivering pharmacologically active agents more selectively to pathological sites (site-specific drug delivery) and/or by guiding them aw...
متن کاملCombination Therapies for Smoking Cessation
Evidence acquisition: A systematic review and meta-analysis of RCTs of pharmacotherapies, BTs, or both were conducted. The Cochrane Library, Embase, PsycINFO, and PubMed databases were systematically searched from inception to July 2015. Inclusion was restricted to RCTs reporting biochemically validated abstinence at 12 months. Direct and indirect comparisons were made in 2015 between therapies...
متن کاملCombination pharmaceutical therapies for obesity
published by Anonymous (not verified) on Tue, 10/08/2013 10:39am Title Combination pharmaceutical therapies for obesity. Publication Type Journal Article Year of Publication 2009 Authors Gadde, KM, Allison, DB Journal Expert Opin Pharmacother Volume 10 Issue 6 Pagination 921-5 Date Published 2009 Apr ISSN 1744-7666
متن کاملCombination antithrombotic therapies.
Atherothrombosis is the major pathophysiological process responsible for the occurrence of severe ischemic events in patients with cardiovascular diseases. In the United States, atherothrombosis strongly influenced mortality in 2004: One in 2.8 deaths was due to CVD, 1 in 5 deaths to coronary heart disease, and 1 in 17 deaths to stroke.1 Because cardiovascular disease is a progressive and syste...
متن کاملMethods for optimizing antiviral combination therapies
MOTIVATION Despite some progress with antiretroviral combination therapies, therapeutic success in the management of HIV-infected patients is limited. The evolution of drug-resistant genetic variants in response to therapy plays a key role in treatment failure and finding a new potent drug combination after therapy failure is considered challenging. RESULTS To estimate the activity of a drug ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Genetics
سال: 2016
ISSN: 1471-0056,1471-0064
DOI: 10.1038/nrg.2016.52